Intravesical administration of radiolabelled tumour-associated monoclonal antibody in bladder cancer

Acta Oncologica

Volumn 38, Issue 3, 1999, Pages 379-382

  Syrigos, Konstantinos N ^a   Khawaja, Magsood ^a   Krausz, Thomas ^a   Williams, Gordon ^a   Epenetos, Agamemnon A ^b  

^a Department of Clinical Oncology ^*  (Greece)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; MONOCLONAL ANTIBODY;

ARTICLE; BLADDER CANCER; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAVESICAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RADIOISOTOPE DISTRIBUTION; RADIOISOTOPE THERAPY;

ADMINISTRATION, INTRAVESICAL; ANTIBODIES, MONOCLONAL; CA-15-3 ANTIGEN; HUMANS; IMMUNOHISTOCHEMISTRY; RADIOIMMUNOTHERAPY; TISSUE DISTRIBUTION; URINARY BLADDER NEOPLASMS;

EID: 0033003539     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699431474     Document Type: Article

References (19)

1. 1. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-7.
2. 2. Kohler G, Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 1976; 6: 511-9.
3. 3. Silverberg E, Lubera JA. Cancer statistics, 1989. CA Cancer J Clin 1989; 39: 3-20.
4. 4. Tolley DA, Hargreave TB, Smith PH, et al. Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J Clin Res Ed 1988; 296: 1759-61.
5. 5. Tolley DA, Parmar MK, Grigor KM, et al. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol 1996; 155: 1233-8.
6. 6. Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990. CA Cancer J Clin 1990; 40: 9-26.
7. 7. Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP. Biology and management of bladder cancer. N Engl J Med 1990; 322: 1129-38.
8. 8. Heney NM, Nocks BN, Daly JJ, et al. Ta and T1 bladder cancer: location, recurrence and progression. Br J Urol 1982; 54: 152-7.
9. 9. Taylor-Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL. Bodmer WF. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer 1981; 28: 17-21.
10. 10. Conn IG, Crocker J, Emtage LA, Wallace DMA. HMFG2 as a prognostic indicator in superficial bladder cancer. J Clin Pathol 1991; 41: 1191-5.
11. 11. Arklie J, Taylor-Papadimitriou J, Bodmer W, Egan M, Millis R. Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer 1981; 28: 23-9.
12. 12. Burchell J, Durbin H, Taylor-Papadimitriou J. Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. J Immunol 1983; 131: 508-13.
13. 13. Fraker PJ, Speck JC Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849-57.
14. 14. Syrigos KN, Epenetos AA. Radioimmunotherapy of ovarian cancer. Hybridoma 1995; 14: 121-4.
15. 15. Kunkler RB, Bishop MC, Green DJ, Pimm MV, Price MR, Frier M. Targeting of bladder cancer with monoclonal antibody NCRC48 a possible approach for intravesical therapy. Br J Urol 1995; 76: 81-6.
16. 16. Bamias A, Bowles MJ, Krausz T, Williams G, Epenetos AA. Intravesical administration of indium-111-labelled HMFG2 monoclonal antibody in superficial bladder carcinomas. Int J Cancer 1993; 54: 899-903.
17. 17. Bamias A, Keane P, Krausz T, Williams G, Epenetos AA. Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma. Cancer Res 1991; 51: 724-8.
18. 18. Li L, Zhang Y, Lin Q, Li C, Hc M. Clinical application of monoclonal antibody-drug conjugate to immunotargeting chemotherapy of bladder cancer. Chin Med J Engl 1995; 108: 764-8.
19. 19. Syrigos KN, Rowlinson-Busza G, Epenetos AA. In vitro cytotoxicity following specific activation of amygdalin by β-glucosidase conjugated to a bladder cancer-associated monoclonal antibody. Int J Cancer (in press).